By — Shyamal Sinha
Bhutan will go on lockdown for seven days starting from Tuesday amid rising case of Covid-19 cases, announced Bhutan Prime Minister Lotay Tshering.
In a statement, Tshering announced that a nationwide lockdown will be enforced for seven days, starting December 23, adding that the lockdown will enable the government to control the spread of the disease and also discern the extent of transmission in the communities.
“In continuation to the inter-district movement restriction imposed this morning, the national COVID-19 Taskforce decided the need for a more stringent action after detection of sporadic cases in flu clinics in Thimphu and Paro, and also in Lhamoizingkha, which is evident of local transmission,” the statement read.
As per a bulletin by Ministry of Health of the Himalayan Kingdom on December 22, the total number of COVID-19 cases stood at 479 out of which 430 have recovered. Bhutan is yet to record a COVID-19 fatality.
While only designated shops within the zones and essential services will be available, all schools, institutions, offices and business establishments should remain closed.
Similarly, movement of individuals with the card within the zones and delivery of essentials will start in Thimphu tomorrow, as it completes the third day of lockdown. However, zone relaxation will not apply to houses under isolation, the statement noted.
Recently, Bhutan’s ambassador to India Vetsop Namgyel stated that India’s vaccines will be the ‘easiest to administer and transport’ as the country is ‘known to produce in bulk quantities’.
Hailing India, the Bhutan Ambassador said, “Vaccines in India are the ones which will be easiest to administer and transport. Most countries will benefit from it. India is known to produce in bulk quantities, once approved it can be rolled out quickly.”
Union Health Secretary Rajesh Bhushan has said that there are six COVID-19 vaccine candidates in different clinical trial stages being developed by various manufacturers in India. Besides this, three COVID-19 vaccine candidates are in the pre-clinical stage of which one of the Coronavirus vaccine candidates is in the pre-development stage being researched by Aurobindo Pharma, the official said.
source — ANI
